We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-2.00 | -0.15% | 1,320.00 | 1,322.50 | 1,323.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
1,323.50 | 1,302.50 | 1,308.50 | 13,999,772 | 16:35:19 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1889 | 11.12 | 54.8B |
Date | Time | Source | Headline |
---|---|---|---|
20/12/2024 | 09:00 | UK RNS | GSK PLC Block Listing Application |
20/12/2024 | 08:58 | ALNC | GSK reports mixed findings from ovarian cancer phase III study |
20/12/2024 | 07:00 | UK RNS | GSK PLC Headline results from phase III FIRST trial |
16/12/2024 | 09:34 | ALNC | GSK receives three positive regulatory updates on cancer products |
16/12/2024 | 07:11 | UK RNS | GSK PLC Jemperli receives US FDA breakthrough designation |
16/12/2024 | 07:05 | UK RNS | GSK PLC EMA grants PRIME Designation for GSK’227 |
16/12/2024 | 07:00 | UK RNS | GSK PLC Jemperli receives positive CHMP opinion |
12/12/2024 | 15:30 | UK RNS | GSK PLC Director/PDMR Shareholding |
09/12/2024 | 19:42 | ALNC | IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial |
09/12/2024 | 18:29 | UK RNS | GSK PLC Overall survival data presented for Blenrep |
1 Year Gsk Chart |
Intraday Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions